Evaluating the role of PET-CT in managing invasive fungal infections
Official title: A Prospective Multicenter Study to Determine the Usefulness of Systematic 18-FDG-PET-TC for the Management of Invasive Fungal Infection (PETIFI Project)
Run by Puerta de Hierro University Hospital · NCT05688592 · Data updated 2026-11-12
This study is testing if a special type of scan called PET-CT can help doctors better manage invasive fungal infections compared to regular imaging methods.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 224 (estimated) |
| Sponsor | Puerta de Hierro University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 14 sites (Majadahonda, Madriid and 13 other locations) |
| Status | Recruiting |
| Started | April 27, 2023 |
| Main results expected | October 31, 2024 |
| Study ends | December 1, 2024 |
| Registry record updated | November 6, 2024 |
| Trial ID | NCT05688592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with invasive fungal infections who can undergo a PET-CT scan.
✕Probably not a fit
Patients with active bacterial infections, recent surgeries in the affected area, or other medical conditions that may interfere with the study will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This national multicenter prospective cohort study aims to assess the added value of 18F-FDG PET-CT in the management of invasive fungal infections (IFI). It will compare the effectiveness of PET-CT against conventional radiological studies in terms of disease characterization, staging, and monitoring treatment response. Participants will undergo a PET-CT scan as part of their diagnostic work-up, and researchers will analyze how this imaging technique influences patient management and prognostic evaluations. The study will include patients with fungemia and focal IFIs, following established diagnostic criteria.
Why it matters
Potential benefit: If successful, this study could enhance the management and outcomes of patients with invasive fungal infections by providing more accurate diagnostic and prognostic information.
How similar studies have gone: While the use of PET-CT in fungal infections is not widely established, preliminary literature suggests that similar approaches may yield promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * 18-year-old adult patients * who are admitted with a diagnosis of invasive fungal infection * who able to undergo a one 18F-FDG PET-CT * who give their informed consent. Exclusion criteria: * concomitant active bacterial infection likely to produce uptake in organs and tissues * recent surgery in the area of the IFI (in the previous 3 months) * other medical conditions that interfere with the development of the study ( e.g., inability to tolerate the performance of the test during the required time, pregnancy) * terminal situation.
Where it's running
-
Hospital Universitario Puerta de Hierro
Majadahonda, Madriid, Spain Recruiting -
Hospital de Bellvitge
Barcelona, Spain Recruiting -
Hospital Universitario Clinic
Barcelona, Spain Recruiting -
Hospital Universitario Virgen de las Nieves
Granada, Spain Recruiting -
Hospital Infanta Leonor Hospital
Madrid, Spain Recruiting -
Hospital Universitario Gregorio Marañón
Madrid, Spain Recruiting
Show 8 more locations
-
Hospital Universitario La Paz
Madrid, Spain Recruiting -
Hospital Unversitario Ramón y Cajal
Madrid, Spain Recruiting -
Hospital Virgen de la Victoria
Málaga, Spain Recruiting -
Hospital Universitario Central de Asturias
Oviedo, Spain Recruiting -
Hospital Unversitario de Salamanca
Salamanca, Spain Recruiting -
Hospital Universitario Virgenn de la Macarena
Seville, Spain Recruiting -
Hospital Morales Messeguer
Murcia, Spain Not yet recruiting -
Hospital Virgen de la Arrixaca
Murcia, Spain Not yet recruiting
Study contacts
- Principal investigator: Ana Fernández Cruz, MDPhD — Hospital Puerta de Hierro-Majadahonda
- Study coordinator: Andrea Gutiérrez Villanueva, MD
- Email: a.gutierrezv@hotmail.com
- Phone: +34618157518
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
Low-dose liposomal amphotericin B to prevent invasive fungal infections in neutropenic children
This study tests whether giving a fixed low dose of liposomal amphotericin B can prevent invasive fungal infections in children aged 3–17 who are severely neutropenic after hematopoietic stem cell transplantation or similar high-risk conditions.
-
Breath analysis to detect fungal infections in leukemia patients
This study is testing if analyzing breath samples can help doctors detect fungal infections in leukemia patients who are at high risk due to their treatment.
-
Using a special PET scan to detect invasive fungal infections
This study is testing a special PET scan with a new tracer to see if it can help find invasive fungal infections in people who have recently been diagnosed.
-
Non-invasive diagnosis of lung infections caused by mold in children
This study is testing a new, non-invasive way to find lung infections caused by mold in children who are at high risk due to serious health conditions.
-
Tracking invasive fungal infections after allogeneic hematopoietic stem cell transplant
We will follow people who had an allogeneic stem cell transplant to see how often serious fungal infections occur and which clinical factors predict them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.